EARLY DIAGNOSIS OF ALZHEIMER'S DISEASE: IMPORTANCE AND CHALLENGES
PDF (Português (Brasil))

Keywords

Alzheimer’s, Early Diagnosis.

How to Cite

Roller, L. de F., Carvalho, G. L. de, Terra, M. C., Dias, I. L., Arantes, P. T. de A., Gondim, L. F., Rocha, J. P. O. da, Bastos, J. R. N., Veloso, L. Q. S., Gamboge, L. R. R., Azeredo , F. R. P., Duarte , D. S., Cattani , J., Rocha, I. C. F. da, & Wanzeller , A. S. da S. (2024). EARLY DIAGNOSIS OF ALZHEIMER’S DISEASE: IMPORTANCE AND CHALLENGES. Brazilian Journal of Implantology and Health Sciences, 6(3), 2778–2786. https://doi.org/10.36557/2674-8169.2024v6n3p2778-2786

Abstract

Alzheimer's disease is a neurodegenerative disorder common in older people and its pathophysiology is not yet well explained, but it is known that genetic factors are involved in its development.  It is a chronic pathology that presents senile plaques and is characterized by a progressive decline in cognitive function, with damage mainly to short-term memory, language, reasoning and critical judgment. In view of the epidemiological impact of Alzheimer's disease, this paper aims to address the importance of early diagnosis of the disease, in order to highlight the challenges faced in its diagnosis. The study was based on a literature review. The articles were selected for the study after searching the SciELO, PubMed and VHL databases.  The descriptors used to find the related studies were "Alzheimer's Disease" and "Early Diagnosis".  As a result, it was observed that early diagnosis of Alzheimer's disease is of paramount importance for adequate access to treatment, planning and preparing the family for future challenges, seeking emotional support, safety and adequate care. However, challenges such as intra-laboratory variability, overlap with other forms of dementia and high cost mean that early diagnosis using biomarkers is limited.

https://doi.org/10.36557/2674-8169.2024v6n3p2778-2786
PDF (Português (Brasil))

References

AULD DS, KORNECOOK TJ, BASTIANETTO S, QUIRION R. Alzheimer's disease and the basal forebrain cholinergic system: relations to beta-amyloid peptides, cognition and treatment strategies. Prog Neurobiol. 2002;68(3):209-45.

Ballard C, Gauthier S, Corbett A, Brayne C, Aarsland D, Jones E Lancet. 2011 Mar;377(9770):1019-31. Epub 2011 Mar 1.

BILLMANN, A.; PEZZINI, M. F.; POETA, J. Biomarcadores no Líquido Cefalorraquidiano no Desenvolvimento da Doença de Alzheimer: uma revisão sistemática. Revista Psicologia e Saúde, [S.L.], p. 141-154, 3 jul. 2019. Universidade Católica Dom Bosco. http://dx.doi.org/10.20435/pssa.v0i0.927

BLENNERHASSETT R, ET AL. Distribution of pathology in frontal variant Alzheimer's disease. J Alzheimers Dis. 2014;39(1):63.

SANTOS, MICHELLE DIDONE; BORGES, SHEILA DE MELO. Percepção da funcionalidade nas fases leve e moderada da doença de Alzheimer: visão do paciente e seu cuidador. Rev. bras. geriatr. gerontol. [online]. 2015, vol.18, n.2, pp.339-349. ISSN 1981-2256. http://dx.doi.org/10.1590/1809-9823.2015.14154.

SILVA, Amanda Moreira Da. REIS, Wander Parente Dos. CORREIA, Aline Roepke Loss. Doença De Alzheimer: A Importância Do Diagnóstico Precoce. Revista Científica Multidisciplinar Núcleo do Conhecimento. Ano 06, Ed. 05, Vol. 08, pp. 136-153. Maio de 2021. ISSN: 2448-0959

SELKOE D. Alzheimer's disease: genes, proteins, and therapy. Physiol Rev. 2001;81(2):741- 66.

SOUZA, LEONARDO CRUZ DE et al. Biological markers of Alzheimer's disease. Arquivos de Neuro-Psiquiatria [online]. 2014, v. 72, n. 3

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright (c) 2024 Luísa de Faria Roller, Gabriel Leão de Carvalho, Mariná Campos Terra, Isabela Lima Dias, Pedro Tiago de Araújo Arantes, Letícia Floro Gondim, Joice Priscila Oliveira da Rocha, José Rodolfo Nascimento Bastos, Luísa Quintino Soares Veloso, Lauanda Raíssa Reis Gamboge, Fernanda Ribeiro Pinto Azeredo , Danilo Samy Duarte , Júlia Cattani , Inês Chagas Ferreira da Rocha, Arthur Sterdys da Silva Wanzeller